Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugate vaccine in adults ≥65 years old.

Vaccine（2023）

引用 0|浏览10

暂无评分

摘要

ClinicalTrials.gov, NCT04887948.

查看译文

关键词

20-valent pneumococcal conjugate vaccine,Coadministration,COVID-19,SARS-CoV-2,Streptococcus pneumoniae

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要